Literature DB >> 9498947

Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency.

P K Stein1, P Nelson, J N Rottman, D Howard, S M Ward, R E Kleiger, R M Senior.   

Abstract

BACKGROUND: Analysis of heart rate variability (HRV) is a powerful method of assessing severity of conditions affecting the autonomic nervous system. STUDY
OBJECTIVE: To determine if HRV is decreased and if HRV reflects severity in COPD.
DESIGN: Prospective determination of HRV from 24-h outpatient Holter recordings. PATIENTS: Eighteen individuals with PiZ alpha1-antitrypsin deficiency: 13 with COPD and 5 with normal FEV1. HRV was also determined in 18 matched normal control subjects. Approximately 3 years after the initial recording, all COPD subjects were contacted to determine current status. MEASUREMENTS: Indexes of heart rate (HR) and HRV were compared for groups of patients with and without COPD and their control subjects.
RESULTS: Mean and minimum HRs were higher in COPD patients. Virtually all indexes of HRV were significantly decreased in COPD patients. No differences were found in HR or HRV between PiZ individuals with normal FEV1 and their age-and gender-matched control subjects. Patients who had a change in status (ie, death, lung transplant, listed for transplant) had significantly higher daytime HRs, lower values for HRV indexes reflecting mixed sympathetic and parasympathetic modulation of HR, and reduced daytime high-frequency spectral power, an index of cardiac vagal modulation. Significant correlations (r=0.48 to 0.88) were found between FEV1 and these and other indexes of HRV. Most other indexes of HRV also tended to be lower for the group whose status had changed.
CONCLUSION: PiZ alpha1-antitrypsin deficiency COPD is associated with abnormal cardiac autonomic modulation. Indexes of HRV appear to reflect severity and may have prognostic value in COPD patients.

Entities:  

Mesh:

Year:  1998        PMID: 9498947     DOI: 10.1378/chest.113.2.327

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Effects of aerobic exercise training and irbesartan on blood pressure and heart rate variability in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Fracois Maltais; Yves Lacasse; Yves Lacourciere; Claudette Fortin; Paul Poirier
Journal:  Can Respir J       Date:  2008-10       Impact factor: 2.409

2.  Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD).

Authors:  Arnoldus J R van Gestel; Joerg Steier
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

3.  Predictors of improvement in resting heart rate after exercise training in patients with chronic obstructive pulmonary disease.

Authors:  İlknur Naz; Hülya Şahin; Büşra Aktaş
Journal:  Ir J Med Sci       Date:  2021-09-11       Impact factor: 2.089

4.  Anxiety Is a Mediator between Heart Rate Variability and Quality of Life in Chronic Obstructive Pulmonary Disease.

Authors:  Da-Wei Wu; Li-Hsin Chang; Po-Chou Yang; Tzu-Yu Kuo; Dong-Lin Tsai; Huang-Chi Chen; Hui-Lan Yuan; Pei-Shih Chen; Szu-Chia Chen; I-Mei Lin
Journal:  J Pers Med       Date:  2022-06-12

5.  Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion.

Authors:  Tufan Tükek; Pinar Yildiz; Vakur Akkaya; Mehmet Akif Karan; Dursun Atilgan; Veysel Yilmaz; Ferruh Korkut
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

6.  Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life.

Authors:  Jennifer L Black-Shinn; Gregory L Kinney; Anastasia L Wise; Elizabeth A Regan; Barry Make; Mori J Krantz; R Graham Barr; James R Murphy; David Lynch; Edwin K Silverman; James D Crapo; John E Hokanson
Journal:  COPD       Date:  2014-05-15       Impact factor: 2.409

7.  Heart rate variability in association with frequent use of household sprays and scented products in SAPALDIA.

Authors:  Amar J Mehta; Martin Adam; Emmanuel Schaffner; Jean-Claude Barthélémy; David Carballo; Jean-Michel Gaspoz; Thierry Rochat; Christian Schindler; Joel Schwartz; Jan-Paul Zock; Nino Künzli; Nicole Probst-Hensch
Journal:  Environ Health Perspect       Date:  2012-04-22       Impact factor: 9.031

Review 8.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

9.  Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.

Authors:  Joseph Finkelstein; Eunme Cha; Steven M Scharf
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-24

Review 10.  Controlled human exposures to ambient pollutant particles in susceptible populations.

Authors:  Yuh-Chin T Huang; Andrew J Ghio
Journal:  Environ Health       Date:  2009-07-25       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.